Shares of small-cap biopharmaceutical company Citius Pharmaceuticals plummeted nearly 19% on Friday, November 22, hitting an all-time low after the company announced a reverse stock split to regain compliance with listing requirements. Details Citius Pharma’s stock dropped 18.8% on the Nasdaq on Friday to close at $0.13 per share —…